Search Results - Wenfeng Fang

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI

    Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI by Yiming ZENG, Wenfeng FANG, Li ZHANG

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors

    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors by Zihong Chen, Gang Chen, Yuxiang Ma, Hongyun Zhao, Jianhua Zhan, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Wenfeng Fang, Li Zhang, Yaxiong Zhang

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

    Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. by Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiaoxiao Dinglin, Ying Tian, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang

    Published 2014-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: